These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 27232956)

  • 1. Treatment of Gram-negative bacterial infections by potentiation of antibiotics.
    Zabawa TP; Pucci MJ; Parr TR; Lister T
    Curr Opin Microbiol; 2016 Oct; 33():7-12. PubMed ID: 27232956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMT-P8 potentiates Gram-positive specific antibiotics in intrinsically resistant Gram-negative bacteria.
    Singh V; Nandanwar H
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0075324. PubMed ID: 39235250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance.
    MacNair CR; Brown ED
    mBio; 2020 Sep; 11(5):. PubMed ID: 32963002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
    Brown P; Dawson MJ
    J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of gram-negative bacteria.
    Savage PB
    Ann Med; 2001 Apr; 33(3):167-71. PubMed ID: 11370769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxins and their novel derivatives.
    Vaara M
    Curr Opin Microbiol; 2010 Oct; 13(5):574-81. PubMed ID: 20869908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria.
    Domalaon R; Brizuela M; Eisner B; Findlay B; Zhanel GG; Schweizer F
    Amino Acids; 2019 Mar; 51(3):383-393. PubMed ID: 30392097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics.
    Panjla A; Kaul G; Shukla M; Akhir A; Tripathi S; Arora A; Chopra S; Verma S
    Biomed Pharmacother; 2024 Jul; 176():116810. PubMed ID: 38823276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin antibiotics for gram-negative infections.
    Arnold TM; Forrest GN; Messmer KJ
    Am J Health Syst Pharm; 2007 Apr; 64(8):819-26. PubMed ID: 17420197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High specific selectivity and Membrane-Active Mechanism of the synthetic centrosymmetric α-helical peptides with Gly-Gly pairs.
    Wang J; Chou S; Xu L; Zhu X; Dong N; Shan A; Chen Z
    Sci Rep; 2015 Nov; 5():15963. PubMed ID: 26530005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to polymyxins: Mechanisms, frequency and treatment options.
    Falagas ME; Rafailidis PI; Matthaiou DK
    Drug Resist Updat; 2010; 13(4-5):132-8. PubMed ID: 20843473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
    Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
    J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silver enhances antibiotic activity against gram-negative bacteria.
    Morones-Ramirez JR; Winkler JA; Spina CS; Collins JJ
    Sci Transl Med; 2013 Jun; 5(190):190ra81. PubMed ID: 23785037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will new antimicrobials overcome resistance among Gram-negatives?
    Bassetti M; Ginocchio F; Mikulska M; Taramasso L; Giacobbe DR
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):909-22. PubMed ID: 21973303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lack of synergy between membrane-permeabilizing cationic antimicrobial peptides and conventional antibiotics.
    He J; Starr CG; Wimley WC
    Biochim Biophys Acta; 2015 Jan; 1848(1 Pt A):8-15. PubMed ID: 25268681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Mechanisms of the Synthesized Antimicrobial Peptide TS against Gram-Negative Bacteria for High Efficacy Antibacterial Action In Vivo.
    Zhang R; Fan X; Jiang X; Zou M; Xiao H; Wu G
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections.
    Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF
    mBio; 2020 Sep; 11(5):. PubMed ID: 32934086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria.
    Liu Y; Li R; Xiao X; Wang Z
    Crit Rev Microbiol; 2019 May; 45(3):301-314. PubMed ID: 30985240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections.
    Huwaitat R; McCloskey AP; Gilmore BF; Laverty G
    Future Microbiol; 2016 Jul; 11():955-72. PubMed ID: 27357521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.